25.88 USD
+0.18
0.70%
Updated Aug 26, 11:25 AM EDT
1 day
0.70%
5 days
-0.61%
1 month
22.54%
3 months
12.38%
6 months
42.04%
Year to date
21.10%
1 year
29.27%
5 years
-17.47%
10 years
-24.68%
 

About: Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.

Employees: 2,900

0
Funds holding %
of 7,431 funds
0
Analysts bullish %
of 6 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

200% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 3 (+2) [Q2]

25% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 44

11% more capital invested

Capital invested by funds: $1.49B [Q1] → $1.65B (+$165M) [Q2]

7.08% more ownership

Funds ownership: 84.38% [Q1] → 91.45% (+7.08%) [Q2]

2% more funds holding

Funds holding: 266 [Q1] → 271 (+5) [Q2]

2% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 96

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$21
19%
downside
Avg. target
$26
1%
downside
High target
$28
8%
upside

6 analyst ratings

positive
0%
neutral
83%
negative
17%
Piper Sandler
Jessica Tassan
8%upside
$28
Neutral
Maintained
25 Aug 2025
UBS
Kevin Caliendo
0%upside
$26
Neutral
Maintained
20 Aug 2025
Canaccord Genuity
Richard Close
3%downside
$25
Hold
Maintained
20 Aug 2025
Baird
Eric Coldwell
4%upside
$27
Neutral
Maintained
20 Aug 2025
B of A Securities
Michael Cherny
19%downside
$21
Underperform
Maintained
19 Aug 2025

Financial journalist opinion

Based on 12 articles about PINC published over the past 30 days

Positive
Benzinga
5 days ago
Premier Analysts Increase Their Forecasts Following Better-Than-Expected Results
Premier, Inc. PINC reported better-than-expected fourth-quarter financial results on Tuesday.
Premier Analysts Increase Their Forecasts Following Better-Than-Expected Results
Negative
Benzinga
6 days ago
Top 2 Health Care Stocks That May Fall Off A Cliff In August
As of Aug. 20, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Top 2 Health Care Stocks That May Fall Off A Cliff In August
Positive
Schwab Network
6 days ago
Overlooked Stock: PINC 2-Year High After Earnings
Premier (PINC) rebounded to 2023 levels after posting better-than-expected earnings and signaling more share buybacks. George Tsilis talks about the rise in the healthcare company's stock price and how it compares to competitors like Cardinal Health (CAH).
Overlooked Stock: PINC 2-Year High After Earnings
Neutral
Seeking Alpha
1 week ago
Premier, Inc. (PINC) Q4 2025 Earnings Call Transcript
Premier, Inc. (NASDAQ:PINC ) Q4 2025 Earnings Conference Call August 19, 2025 8:00 AM ET Company Participants Ben Krasinski - Director of Investor Relations David P. Zito - President of Performance Services Glenn G.
Premier, Inc. (PINC) Q4 2025 Earnings Call Transcript
Positive
Zacks Investment Research
1 week ago
Here's What Key Metrics Tell Us About Premier (PINC) Q4 Earnings
Although the revenue and EPS for Premier (PINC) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Here's What Key Metrics Tell Us About Premier (PINC) Q4 Earnings
Positive
Zacks Investment Research
1 week ago
Premier, Inc. (PINC) Tops Q4 Earnings and Revenue Estimates
Premier, Inc. (PINC) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.69 per share a year ago.
Premier, Inc. (PINC) Tops Q4 Earnings and Revenue Estimates
Neutral
Business Wire
1 week ago
Premier, Inc. Reports Fiscal-Year 2025 Fourth-Quarter and Full-Year Financial Results
CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2025 fourth quarter and full year ended June 30, 2025. Fiscal-year 2025 fourth quarter total net revenue of $262.9 million decreased 12% from the prior-year period; however, increased 1% on a sequential basis from the fiscal-year 2025 third quarter. Net income from continuing operations of $18.0 million, or $0.22 per sha.
Premier, Inc. Reports Fiscal-Year 2025 Fourth-Quarter and Full-Year Financial Results
Neutral
Business Wire
1 week ago
Premier, Inc. Declares Quarterly Cash Dividend
CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common stock issued and outstanding. The cash dividend will be payable on September 15, 2025, to stockholders of record as of the close of business on September 1, 2025. About Premier, Inc. Premier, Inc. (NASDAQ: PINC) is a leading technology-driven healthcare improvement com.
Premier, Inc. Declares Quarterly Cash Dividend
Neutral
Zacks Investment Research
1 week ago
Countdown to Premier (PINC) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Evaluate the expected performance of Premier (PINC) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Countdown to Premier (PINC) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Neutral
Business Wire
2 weeks ago
AIS Healthcare Awarded a Group Purchasing Agreement for 503A Intrathecal Compounded Medications with Premier, Inc.
DALLAS--(BUSINESS WIRE)--AIS Healthcare has been awarded a group purchasing agreement for 503A intrathecal compounded medications with Premier, Inc., effective July 1, 2025. The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for sterile, patient-specific intrathecal pain pump medications. In addition, to assist with compliance policies, this agreement with Premier will provide member hospitals with site audit e.
AIS Healthcare Awarded a Group Purchasing Agreement for 503A Intrathecal Compounded Medications with Premier, Inc.
Charts implemented using Lightweight Charts™